Section Arrow
OSUR.NASDAQ
- OraSure Technologies
Quotes are at least 15-min delayed:2026/02/17 19:25 EST
After Hours
Last
 2.7
-0.05 (-1.82%)
Bid
2.6
Ask
2.93
High 2.8 
Low 2.69 
Volume 4.76K 
Regular Hours (Closed)
Last
 2.75
0 (0.00%)
Day High 
2.79 
Prev. Close
2.75 
1-M High
3.005 
Volume 
388.05K 
Bid
2.6
Ask
2.93
Day Low
2.68 
Open
2.73 
1-M Low
2.59 
Market Cap 
197.27M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 2.81 
20-SMA 2.76 
50-SMA 2.61 
52-W High 4.22 
52-W Low 2.08 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.81/0.24
Enterprise Value
209.70M
Balance Sheet
Book Value Per Share
5.05
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
405.47M
Operating Revenue Per Share
6.31
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BAXBaxter International20.74+0.95+4.80%-- 
After Hours 20.671 -0.069 -0.33%
AVTRAvantor9.05-0.15-1.63%-- 
After Hours 9.26 +0.21 +2.32%
XRAYDENTSPLY SIRONA12.44-0.51-3.94%-- 
After Hours 12.69 +0.25 +2.01%
NVSTEnvista Holdings Corp28.07-0.9-3.11%321.89PE
After Hours 28.03 -0.04 -0.14%
WRBYWarby Parker21.96-0.5-2.23%-- 
After Hours 22.38 +0.42 +1.91%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.